EVP, Chief Financial Officer
EVP, Chief Financial Officer at ALNYLAM PHARMACEUTICALS, INC., filing insider transactions between 2026-02-13 and 2026-03-04.
| SEC ↗ |
| 2026-03-04 | ALNY | Sale | 309 | $321.82 | $99K | SEC ↗ |
| 2026-03-04 | ALNY | Sale | 374 | $323.01 | $121K | SEC ↗ |
| 2026-03-04 | ALNY | Sale | 818 | $323.84 | $265K | SEC ↗ |
| 2026-03-04 | ALNY | Sale | 291 | $324.88 | $95K | SEC ↗ |
| 2026-03-04 | ALNY | Sale | 223 | $325.67 | $73K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 65 | $323.62 | $21K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 124 | $324.65 | $40K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 356 | $325.63 | $116K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 541 | $326.81 | $177K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 454 | $327.67 | $149K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 138 | $328.71 | $45K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 234 | $329.71 | $77K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 112 | $330.85 | $37K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 129 | $331.93 | $43K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 53 | $332.64 | $18K | SEC ↗ |
| 2026-02-13 | ALNY | Sale | 2,242 | $310.08 | $695K | SEC ↗ |